Skip to main content

Table 1 Statistic results of the general clinical characteristics between the two groups

From: Evaluation of the therapeutic effect of high-flow nasal cannula oxygen therapy on patients with aspiration pneumonia accompanied by respiratory failure in the post-stroke sequelae stage

Observation indexes

Venturi group

N = 45

HFNC group

N = 42

χ2 OR t value

P value

Female, n (%)*

23 (51.1)

22 (52.4)

0.014

0.906

Age ≥ 75 years old, n (%)*

21 (46.7)

25 (59.5)

1.441

0.230

The proportion of those with multiple organ failure n (%)Δ

29 (64.4)

15 (35.7)

7.174

0.007

Involved organ

    

 Lung

45 (100)

42 (100)

  

 Kidney

8 (17.8)

6 (14.3)

  

 Circulation

7 (15.6)

4 (9.5)

  

 Blood

5 (11.1)

1 (2.4)

  

 Gastrointestinal

9 (20.0)

4 (9.5)

  

Co-morbidities

    

 Chronic left heart failure (NYHA III or IV), n (%)*

10 (22.2)

13 (40.0)

0.851

0.356

 Diabetes mellitus, n (%)*

22 (48.9)

18 (42.9)

0.318

0.573

 Chronic obstructive pulmonary disease (COPD), n (%)Δ

9 (20)

19 (45.2)

6.340

0.012

State of somnolence, n (%)*

23 (51.1)

18 (42.9)

0.594

0.441

Duration of strokeΔ

  

5.984

0.014

 ≥ 48 weeks, n (%)

31 (68.9)

18 (42.9)

  

 < 48 weeks, n (%)

14 (31.1)

24 (57.1)

  

(Rehabilitative therapies 48 weeks after stroke)*

  

0.900

0.343

 Yes, n (%)

19 (42.2)

22 (52.4)

  

 No, n (%)

26 (57.8)

20 (47.6)

  

PaCO2(mmHg) mean (SD)

    

 0H

47.4 (5.4)

46.8 (5.7)

− 0.308

0.761

 After 4 h*

41.6 (3.6)

37.6 (2.9)

− 3.361

0.002

 After 8 hΔ

39.1 (2.7)

35.5 (2.0)

− 4.080

0.000

 After 12 hΔ

37.0 (1.7)

35.5 (1.4)

− 2.598

0.014

 After 24 h*

35.3 (1.9)

34.8 (2.5)

− 0.547

0.588

 After 48 h*

35.5 (1.6)

35.4 (1.6)

− 0.214

0.832

 After 72 h*

36.2 (1.9)

35.9 (1.4)

− 0.521

0.606

Ischemic stroke, n (%)*

16 (35.6%)

17 (40.5%)

0.223

0.636

  1. *No statistical difference between the two different therapeutic groups (P > 0.05)
  2. ΔWith a statistic difference between the two different therapeutic groups (P < 0.05)